Biophytis Valuation
| ALBPS Stock | EUR 0.30 0.01 3.23% |
Biophytis seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Biophytis SA from analyzing the firm fundamentals such as Return On Equity of -6.81, current valuation of (498.56 K), and Shares Owned By Institutions of 0.25 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Biophytis' price fluctuation is out of control at this time. Calculation of the real value of Biophytis SA is based on 3 months time horizon. Increasing Biophytis' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Biophytis' intrinsic value may or may not be the same as its current market price of 0.30, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.3 | Real 0.27 | Hype 0.3 | Naive 0.28 |
The intrinsic value of Biophytis' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Biophytis' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Biophytis SA helps investors to forecast how Biophytis stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biophytis more accurately as focusing exclusively on Biophytis' fundamentals will not take into account other important factors: Biophytis Total Value Analysis
Biophytis SA is presently projected to have takeover price of (498.56 K) with market capitalization of 8.24 M, debt of 6.29 M, and cash on hands of 7 M. The negative valuation of Biophytis may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should thoroughly investigate all of the Biophytis fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(498.56 K) | 8.24 M | 6.29 M | 7 M |
Biophytis Asset Utilization
One of the ways to look at asset utilization of Biophytis is to check how much profit was generated for every dollar of assets it reports. Biophytis SA shows a negative utilization of assets of -0.51 percent, losing €0.005067 for each euro of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each euro of assets it shows. Put another way, asset utilization of Biophytis SA shows how discouraging it operates for each euro spent on its assets.Biophytis Ownership Allocation
Biophytis holds a total of 203.97 Million outstanding shares. Almost 99.75 percent of Biophytis outstanding shares are held by general public with 0.25 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Biophytis Profitability Analysis
Net Loss for the year was (31.25 M) with profit before overhead, payroll, taxes, and interest of 0.About Biophytis Valuation
The stock valuation mechanism determines Biophytis' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Biophytis SA based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Biophytis. We calculate exposure to Biophytis's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Biophytis's related companies.Biophytis SA, a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. The company was founded in 2006 and is headquartered in Paris, France. BIOPHYTIS operates under Biotechnology classification in France and is traded on Paris Stock Exchange. It employs 30 people.
8 Steps to conduct Biophytis' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Biophytis' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Biophytis' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Biophytis' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Biophytis' revenue streams: Identify Biophytis' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Biophytis' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Biophytis' growth potential: Evaluate Biophytis' management, business model, and growth potential.
- Determine Biophytis' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Biophytis' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Biophytis Stock Analysis
When running Biophytis' price analysis, check to measure Biophytis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biophytis is operating at the current time. Most of Biophytis' value examination focuses on studying past and present price action to predict the probability of Biophytis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biophytis' price. Additionally, you may evaluate how the addition of Biophytis to your portfolios can decrease your overall portfolio volatility.